Actinium Pharmaceuticals, Inc. 10-Q filing
Filed 2026-05-08 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001213900-26-053980
- Form type
- 10-Q
- CIK
- 0001388320
- Primary document
- https://www.sec.gov/Archives/edgar/data/1388320/000121390026053980/ea0286467-10q_actinium.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Actinium Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-5.9M | - | - |
| Net Income | $-5.5M | - | - |
| Eps Basic | -0.18 | - | - |
| Eps Diluted | -0.18 | - | - |
| Cash And Equivalents | $42.1M | - | - |
| Total Assets | $45.4M | - | - |
| Total Liabilities | $43.1M | - | - |
| Shareholders Equity | $2.3M | - | - |
| Operating Cash Flow | $-5.9M | - | - |
| Capital Expenditures | $2,000 | - | - |